Brian Keegan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Brian Keegan has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Bin Zhan
Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Department of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA
2 shared publications- Cristina Poveda
Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
2 shared publications - Junfei Wei
Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA
2 shared publications - Leroy Versteeg
Affiliations Texas Children’s Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America, Cell Biology and Immunology Group, Wageningen University & Research, Wageningen, The Netherlands
2 shared publications - Maria Elena Bottazzi
Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, USA
2 shared publications Peter J. Hotez
Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Department of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA; James A. Baker III Institute for Public Policy, Rice University, Houston, TX, USA
2 shared publications
Latest Publications
- Open Access
- 21 October 2021
- Published by Elsevier in Protein Expression and Purification
- Vol. 190, 106003
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate
- 21 October 2021
- Published by Elsevier in Protein Expression and Purification
- Vol. 190, 106003
Open AccessYeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate